Selected Work

Strategy you can measure.

A closer look at programs I've owned end-to-end — the problem as I found it, how I approached it, and what changed as a result.

Enterprise transformation · Program leadership

A two-year data transformation, built without a map

Cylinder Health
2023 – present
50%
Reduction in monthly data pipeline cost
2x
Client growth supported (10–15 → 30+)
0
Data contracts or documentation to start from

The problem

The company's back-end eligibility system was overhauled with no data contracts, documentation, or requirements passed downstream. Reporting ran off fragmented spreadsheets, no two teams defined key metrics the same way, and the executive team had no trusted, shared view of the business to steer by.

What I did

I program-managed a company-wide transformation end to end — reverse-engineering how the application generated and changed data, then redesigning the warehouse around the new identity-management model. I established governance and metric definitions, built a governed analytics layer for non-technical stakeholders, and acted as the internal consultant translating between engineering and every business function. Along the way I re-architected pipelines for incremental processing and rewrote inefficient queries.

The outcome

Leadership now runs retention, growth, and resource decisions off a single source of truth. The platform scaled to support a doubling of enterprise clients while monthly pipeline costs dropped by half — and any data anomaly can now be traced from an executive dashboard back to its source event.

Program leadershipData governanceWarehouse architectureChange managementCost optimization
Measurement strategy · Data products

Turning "engagement" from a hunch into a company-wide metric

Cylinder Health
2024
1
Engagement metric the whole company aligns on
3
Departments brokered to shared definitions
E2E
Owned from diagnosis through execution

The problem

Marketing, Member Services, and Clinical each talked about "member engagement," but no one could measure it consistently — or agree on what it even meant. Without a shared definition, campaigns couldn't be targeted, segments couldn't be compared, and behavioral impact couldn't be quantified.

What I did

I designed a proprietary member engagement index from first principles — diagnosing the measurement gaps, then facilitating the cross-functional conversations to broker a single set of KPI definitions everyone could stand behind. I built the underlying data model and delivered it as an executive-ready metric, then partnered with Marketing and Member Services to integrate it holistically across the member journey.

The outcome

The index is now the primary lens for segmentation and campaign strategy — a new, proprietary data asset that didn't exist before, giving the business a shared language for what "engaged" actually means and how to move it.

KPI strategyCross-functional alignmentData product designStakeholder facilitation
Program architecture · Real-world evidence

Building the evidence portfolio behind FDA submissions and global expansion

Dexcom
2019 – 2022
3
Peer-reviewed papers · 84 citations
2
Global regions expanded (APAC, E. Europe)
1
Patented AI algorithm, scoped to production

The problem

Expanding into new markets and supporting FDA submissions required rigorous real-world evidence — which meant aligning Clinical, Regulatory, Marketing, and Sales around a shared research agenda, a notoriously hard coalition to build across functions with very different incentives.

What I did

I architected and led the real-world evidence program as its primary internal champion — coordinating across four functions to produce evidence that could support both regulatory submissions and commercial positioning. I scoped, designed, and delivered a patented AI-driven algorithm for personalized care from concept through patent submission, and presented the research on international stages to audiences of 100+.

The outcome

The program supported FDA submissions and market expansion into APAC and Eastern Europe. The published research (84 citations) became a competitive-positioning and lead-generation asset for Sales and Marketing, and the patented algorithm created durable IP advantage in the glucose-monitoring market.

Program architectureRegulatory strategyCross-functional leadershipPatented AIResearch
Featured artifact

Sample strategy deck

A representative example of how I frame a data & AI strategy for an executive audience — from diagnosis through a phased roadmap. Coming soon: a shareable walkthrough you can send to a team.

Deck preview — coming soon

Want the version specific to your team?

Every one of these started with a conversation about a problem no one had fully named yet. If that sounds familiar, let's talk.

Get in touch →